IceCure Medical Ltd. (ICCM): Market Cap to Revenue

Symbol and logo of brand IceCure Medical, Ltd. (ICCM)

The revenue multiple level reflects the valuation dynamics of IceCure Medical Ltd (ICCM), where the value 0.60 represents the most recent figure. IceCure Medical Ltd (ICCM) has developed the innovative ProSense system, which destroys neoplasms using cold without the need for full surgery. Business development relies on the sale of profitable disposable probes, which optimizes costs. A team of leading biomedical experts ensures technological growth by focusing on patient needs.

ICCM IceCure Medical, Ltd. P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for IceCure Medical Ltd (ICCM)

- share price and consensus valuation forecast:
General company analysis:ICCM IceCure Medical Ltd.
Core merchandise of IceCure Medical

The P/S multiple determines the market value of a business relative to its current revenue, allowing for an assessment of sales generation efficiency. By analyzing the P/S multiple trend, an investor can observe the dynamics of market expectations in real time. This ratio measures the premium the market is willing to pay per unit of revenue. For IceCure Medical Ltd (ICCM), high commercialization costs for cryoablation and a liquidity deficit make this indicator critical for assessing business viability.

Competitors of IceCure Medical Ltd

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|Pulmonx Corp. - P/S Multiple|Price-to-Revenue Coefficient TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Price-to-Revenue Ratio|Price-to-Sales Ratio SRTS (Sensus Healthcare Inc)|Price-to-Revenue Ratio Zynex Inc|Market Cap to Revenue electroCore Medical (ECOR)|P/S Multiple RBOT|IINN - Price to Sales|Price-to-Revenue Ratio SeaStar Medical ICU|IRIX: Market Cap to Revenue Ratio|INBS: Market Cap to Revenue|Beyond Air, Inc. - Market Cap to Sales Volume|PFSA: P/S Multiple|SSKN - Price-to-Revenue Coefficient|GCTK (GlucoTrack, Inc.) - P/S Multiple|Market Cap to Revenue nanovibronix.com (NAOV)|P/S Multiple VERO|NUWE - Price to Sales|P/S Multiple AEMD (Aethlon Medical)|ASXC - Market Cap to Revenue|AVGR: Market Cap to Revenue|BSGM - P/S Multiple|Cutera, Inc (CUTR) - Price-to-Revenue Ratio|Know Labs Corporation - Market Capitalization-to-Revenue Ratio|NARI (Inari Medical, Inc.) - P/S Multiple|Price to Sales nevro.com NVRO|Market Cap to Revenue RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Market Capitalization-to-Revenue Ratio